Remdesivir
-
U.S. gives full approval to 1st COVID-19 drug for young childrenThe U.S. drug regulator on Monday granted the first full approval for treating COVID-19 in children aged 28 days and older to Gilead Sciences Inc's GILD.O drug remdesivir.HealthApr 25, 2022
-
Canadian officials hopeful COVID-19 treatments will help ease strain on hospitalsA new study suggests the antiviral medication remdesivir could have a “modest but significant effect” on COVID-19 patient outcomes.CanadaJan 20, 2022
-
-
Advertisement
-
COVID-19: Remdesivir drops need for ventilation by half, Canadian study saysThe study, published Wednesday in the Canadian Medical Association Journal, is billed as the largest single-country trial of remdesivir reported to date.CanadaJan 19, 2022
-
-
Advertisement
-
Medical supplies from Canada arrive in India as COVID-19 cases, deaths surge'Canada stands with our friend and partner India as we work to overcome the devastating impact of #COVID19,' Canada's high commissioner to India tweeted.CanadaMay 8, 2021
-
COVID-19 would have been worse without recent advances in scienceThe world was 100% more prepared for COVID-19 than it was for the flu 100 years ago, Dr. David Pride says.CommentaryDec 20, 2020
-
-
Coronavirus therapeutics: A look at COVID-19 treatments in CanadaFrom dexamethasone, remdesivir to monoclonal antibodies and convalescent plasma, we look at the various coronavirus therapies being used in Canada.HealthDec 1, 2020
-
-
WHO’s take on remdesivir leads to more confusion over coronavirus drugsHealth officials around the world are clashing over the use of certain drugs for COVID-19, leading to different treatment options for patients depending on where they live.HealthNov 20, 2020
-
Remdesivir not recommended for hospitalized coronavirus patients, WHO saysThe advice is another setback for the drug, which grabbed worldwide attention as a potentially effective treatment for COVID-19 in the summer after early trials showed some promise.WorldNov 19, 2020
-
-
Advertisement
-
FDA approves first coronavirus drug, may help recoveryThe drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.WorldOct 22, 2020
-
-
Advertisement
-
Calgary man dies after contracting COVID-19 at Foothills hospital; family seeks remdesivir for daughter on ventilatorA Calgary family is mourning the death of their father after he was diagnosed with COVID-19 while being treated at the Foothills hospital. The family is fighting for his daughter, who also tested positive, to have access to remdesivir.CanadaOct 9, 2020
Trending
-
One person is dead and 16 are injured after a shooting at Tuskegee University717 Read
-
Ukraine attacks Moscow with 34 drones, biggest strike on the Russian capital363 Read
-
6.8 magnitude earthquake shakes Cuba after hurricanes and blackouts326 Read
-
The 4B movement: Why some U.S. women are boycotting men after Trump’s win288 Read
-
Canada may need to let Trump be ‘senior partner’ in U.S. relations: GOP critic259 Read
-
‘Moving to Canada’ searches spike after U.S. election, but it’s not so simple245 Read
-
Top Videos
-
Power expected to return soon as Cuba power outage continues16 Viewed
-
Firefighter hailed as hero, carries young girl away from fatal crash15 Viewed
-
Boats wash up on Vancouver beaches during storm15 Viewed
-
Putin outlines Russia’s terms for Ukraine peace talks15 Viewed
-
City of Victoria rejects parking lot sheltering motion11 Viewed
-
Trump’s promises ‘might cause Canadians to bristle,’ former Republican strategist says11 Viewed
-